OTC Viagra too risky, says EMEA
This article was originally published in Scrip
Executive Summary
An OTC presentation of Pfizer's Viagra (sildenafil) would be too risky at this point, said the EU's CHMP around the time Pfizer withdrew its application to switch the product to non-prescription status.